Government Settles with Stryker Biotech for $15 Million, Drops Charges Against Execs – Law.com
The government's case against Stryker Biotech and three of its executives was set to be a rare instance of an off-label marketing case going before a jury. But after only two days of trial, the Boston U.S. attorney's office reached a $15 million ...
Subscribe to LegalLaw247.Com Newsletter
